173 related articles for article (PubMed ID: 30231393)
1. Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many Options.
Jain N; Thompson P; Ferrajoli A; Nabhan C; Mato AR; O'Brien S
Am Soc Clin Oncol Educ Book; 2018 May; 38():580-591. PubMed ID: 30231393
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapies in CLL: Monotherapy Versus Combination Approaches.
Khan M; Siddiqi T
Curr Hematol Malig Rep; 2018 Dec; 13(6):525-533. PubMed ID: 30535947
[TBL] [Abstract][Full Text] [Related]
3. What Is the Role of Chemotherapy in Patients With Chronic Lymphocytic Leukemia?
Cheson BD
Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):723-727. PubMed ID: 28780145
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.
Hilal T; Gea-Banacloche JC; Leis JF
Blood Rev; 2018 Sep; 32(5):387-399. PubMed ID: 29571669
[TBL] [Abstract][Full Text] [Related]
5. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia.
Wendtner CM; Gregor M
Leuk Lymphoma; 2018 Feb; 59(2):300-310. PubMed ID: 28565930
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapies for CLL: Practical issues with the changing treatment paradigm.
Jain N; O'Brien S
Blood Rev; 2016 May; 30(3):233-44. PubMed ID: 26776345
[TBL] [Abstract][Full Text] [Related]
7. Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia.
Mauro FR; Caputo MD; Rosati S; Pepe S; De Benedittis D; De Luca ML; Foà R
Expert Rev Hematol; 2018 Aug; 11(8):601-611. PubMed ID: 29969322
[TBL] [Abstract][Full Text] [Related]
8. Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.
Barrientos JC
Future Oncol; 2016 Sep; 12(18):2077-94. PubMed ID: 27324214
[TBL] [Abstract][Full Text] [Related]
9. Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting.
Bachow SH; Lamanna N
Curr Hematol Malig Rep; 2016 Feb; 11(1):61-70. PubMed ID: 26951237
[TBL] [Abstract][Full Text] [Related]
10. Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K; Puła B; Walewski J
Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
[TBL] [Abstract][Full Text] [Related]
11. New treatment approaches in CLL: Challenges and opportunities in the elderly.
Eichhorst B; Hallek M; Goede V
J Geriatr Oncol; 2016 Sep; 7(5):375-82. PubMed ID: 27491497
[TBL] [Abstract][Full Text] [Related]
12. Expanding the armamentarium for chronic lymphocytic leukemia: A review of novel agents in the management of chronic lymphocytic leukemia.
Marini BL; Samanas L; Perissinotti AJ
J Oncol Pharm Pract; 2017 Oct; 23(7):502-517. PubMed ID: 27357816
[TBL] [Abstract][Full Text] [Related]
13. Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia.
Del Poeta G; Postorino M; Pupo L; Del Principe MI; Dal Bo M; Bittolo T; Buccisano F; Mariotti B; Iannella E; Maurillo L; Venditti A; Gattei V; de Fabritiis P; Cantonetti M; Amadori S
Drugs Today (Barc); 2016 Apr; 52(4):249-60. PubMed ID: 27252989
[TBL] [Abstract][Full Text] [Related]
14. [Advances in the treatment of chronic lymphocytic leukaemia].
Mozas P; Delgado J
Med Clin (Barc); 2016 Nov; 147(10):447-454. PubMed ID: 27431885
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia.
Rossi D; Gerber B; Stüssi G
Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579
[TBL] [Abstract][Full Text] [Related]
16. Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective.
Owen C; Assouline S; Kuruvilla J; Uchida C; Bellingham C; Sehn L
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):627-634.e5. PubMed ID: 26416145
[TBL] [Abstract][Full Text] [Related]
17. How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options.
Yeung CCS; Shadman M
Curr Oncol Rep; 2019 Jul; 21(8):74. PubMed ID: 31327069
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options.
Sharma S; Rai KR
Cancer; 2019 May; 125(9):1432-1440. PubMed ID: 30807655
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease in chronic lymphocytic leukaemia.
García Vela JA; García Marco JA
Med Clin (Barc); 2018 Feb; 150(4):144-149. PubMed ID: 28864095
[TBL] [Abstract][Full Text] [Related]
20. [Treatment strategies for chronic lymphocytic leukemia in the era of novel targeted therapies].
Kojima K
Rinsho Ketsueki; 2020; 61(9):1275-1280. PubMed ID: 33162526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
